Physician Assistant · Belpre, OH
NPI
1558557165
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1818 Washington Blvd Ste H
Belpre, OH, 45714
Phone (740) 423-3618
Groups this clinician bills Medicare through
Medicare paid, 2024
$256K
5,052 services
Medicare patients, 2024
1,134
Average age 75
Drug cost, 2024
$1.7M
1,792 prescriptions
Company payments, 2025
$1,755
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan P Misel was code 17003 (destruction skin lesion), 1,348 times for 325 patients. In total Nathan P Misel billed 5,052 services in 76 codes, and Medicare paid $256K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,348 | 325 | $3.83 | $5,166 |
| 99213 Office E&M - Established | Office | 822 | 622 | $50.29 | $41K |
| 17000 Destruction Skin Lesion | Office | 569 | 463 | $34.96 | $20K |
| 11102 Skin Biopsy | Office | 354 | 306 | $53.98 | $19K |
| 99212 Office E&M - Established | Office | 201 | 174 | $32.01 | $6,435 |
| 99214 Office E&M - Established | Office | 154 | 117 | $70.59 | $11K |
| 12032 Wound Repair - All Levels | Office | 154 | 129 | $187.35 | $29K |
| 11602 Skin Lesion Excision | Office | 97 | 85 | $81.97 | $7,951 |
| 99203 Office E&M - New | Office | 94 | 94 | $59.50 | $5,593 |
| 11103 Skin Biopsy | Office | 91 | 62 | $30.77 | $2,800 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 89 | 17 | $0.81 | $71.91 |
| 99202 Office E&M - New | Office | 76 | 76 | $38.78 | $2,947 |
| 11603 Skin Lesion Excision | Office | 59 | 53 | $91.94 | $5,425 |
| 11622 Skin Lesion Excision | Office | 31 | 30 | $82.33 | $2,552 |
| 69100 Other Organ Systems | Office | 29 | 26 | $43.94 | $1,274 |
By year: 2022 $257K for 7,285 services; 2023 $231K for 6,408 services; 2024 $256K for 5,052 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nathan P Misel prescribed most often to Medicare patients was Mupirocin, with 404 prescriptions and refills. In total Nathan P Misel wrote 1,792 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mupirocin Generic | 404 | 404 | 341 | $2,327 |
| Triamcinolone Acetonide Generic | 145 | 147 | 111 | $1,492 |
| Clobetasol Propionate Generic | 122 | 125 | 75 | $5,791 |
| Ketoconazole Generic | 112 | 114 | 56 | $1,459 |
| Minocycline Hcl Generic | 78 | 101 | 35 | $1,655 |
| Doxycycline Hyclate Generic | 67 | 81 | 58 | $1,192 |
| Betamethasone Dipropionate Generic | 63 | 64 | 35 | $1,880 |
| Dupixent Pen Dupilumab | 59 | 61 | Under 11 | $224K |
| Minoxidil Generic | 59 | 118 | 20 | $504 |
| Terbinafine Hcl Generic | 48 | 87 | 30 | $495 |
| Finasteride Generic | 41 | 97 | 15 | $537 |
| Otezla Apremilast | 34 | 34 | Under 11 | $161K |
| Fluocinonide Generic | 32 | 41 | 19 | $1,622 |
| Ciclopirox Generic | 32 | 34 | 14 | $1,778 |
| Metronidazole Generic | 28 | 28 | 17 | $2,056 |
Brand drugs: 254 claims; generic drugs: 1,538 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathan P Misel $1,755 ($1,755 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $332.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $332 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $278 |
| Janssen Biotech, Inc. JNJ | 11 | $198 |
| Amgen Inc. AMGN | 13 | $192 |
| Galderma Laboratories, L.P. GALD.SW | 15 | $158 |
| Lilly USA, LLC LLY | 10 | $152 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $99.52 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $61.79 |
| UCB, Inc. UCB.BR | 3 | $57.67 |
| Incyte Corporation INCY | 3 | $56.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.